Gene · 715
Papers2,917
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,917
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Complement pathway dysregulation and astrocyte alterations in Down syndrome: evidence from postmortem brain tissue and iPSC-derived astrocytes. | Acta Neuropathol Commun | 2025 | 41350900 | PubTator, text mining | PubMed |
| Sex-Specific Molecular Architecture of Microglia-Mediated Neuronal Pruning Across the Human Lifespan. | Mol Neurobiol | 2025 | 41324815 | PubTator, text mining | PubMed |
| Complement components C1r and C1s promote oral squamous cell carcinoma cell proliferation. | J Oral Biosci | 2025 | 41274675 | PubTator, text mining | PubMed |
| Second-hand smoke exposure modulates plasma proteins linked to detoxification, inflammation and atherothrombosis. | Environ Toxicol Pharmacol | 2025 | 41207518 | PubTator, text mining | PubMed |
| Proteomic and histopathologic profiling reveal molecular features and clinical biomarkers of coronary atherosclerosis. | Biomark Res | 2025 | 41126379 | PubTator, text mining | PubMed |
| Comment on "Could signal peptide complement C1r/C1s, Uegf, and Bmp1, and epidermal growth factor-containing protein 1 be a therapeutic target in the pathogenesis of preeclampsia?" | Rev Assoc Med Bras (1992) | 2025 | 41124558 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing Reveals Rare Genetic Variants in Saudi COVID-19 Patients with Extreme Phenotypes. | Viruses | 2025 | 41012626 | PubTator, text mining | PubMed |
| Amniotic fluid glycoproteins as potential ligands for macrophage galactose-type C-type lectin and their possible implications for immunoregulation during pregnancy. | Sci Rep | 2025 | 41006428 | PubTator, text mining | PubMed |
| Complement and local ocular inflammatory response: Chronic immune factors in myopia. | Sci Prog | 2025 | 41002181 | PubTator, text mining | PubMed |
| An integrated multi-omic natural history study of human development, sexual dimorphism, and the effects of trisomy 21. | Nat Commun | 2025 | 40993118 | PubTator, text mining | PubMed |
| Exploring the Protein-Metabolite Interplay to Discover Novel Drug Targets for Alzheimer's Disease. | J Gene Med | 2025 | 40974265 | PubTator, text mining | PubMed |
| Complement profiling of sural nerves in chronic-inflammatory demyelinating polyneuropathy. | Acta Neuropathol | 2025 | 40971018 | PubTator, text mining | PubMed |
| Heightened innate immunity may trigger chronic inflammation, fatigue and post-exertional malaise in ME/CFS. | NPJ Metab Health Dis | 2025 | 40903540 | PubTator, text mining | PubMed |
| Machine learning analysis reveals tumor heterogeneity and stromal-immune niches in breast cancer. | NPJ Digit Med | 2025 | 40897851 | PubTator, text mining | PubMed |
| Extracellular vesicle proteomic expression is influenced by mining tenure in former uranium miners. | Environ Res | 2025 | 40897222 | PubTator, text mining | PubMed |
| IDH1-dependent m6A methylation defines transcriptomic heterogeneity in glioma. | medRxiv | 2025 | 40894120 | PubTator, text mining | PubMed |
| Antibiotic-resistant Acinetobacter baumannii can be killed by a combination of bacteriophages and complement. | Med Microbiol Immunol | 2025 | 40892293 | PubTator, text mining | PubMed |
| Molecular basis of potent antiviral HLA-C-restricted CD8+ T cell response to an immunodominant SARS-CoV-2 nucleocapsid epitope. | Nat Commun | 2025 | 40877317 | PubTator, text mining | PubMed |
| The role of complement in long COVID pathogenesis. | JCI Insight | 2025 | 40857408 | PubTator, text mining | PubMed |
| Spatial transcriptomic analysis across histological subtypes reveals molecular heterogeneity and prognostic markers in early-stage lung adenocarcinoma. | Clin Transl Med | 2025 | 40847563 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/715/papers?page=3